Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Lymphomatoid papulosis: A cutaneous lymphoproliferative disorder in a patient on fingolimod for multiple sclerosis.
Immune- and miRNA-response to recombinant interferon beta-1a: a biomarker evaluation study to guide the development of novel type I interferon- based therapies.
[Does interferon beta slow the progression of multiple sclerosis? - Long-term effect of IFN-β on progression of physical disability is still not proven].
Early tolerability and safety of fingolimod in clinical practice.
Microsomal prostaglandin E synthase-1 aggravates inflammation and demyelination in a mouse model of multiple sclerosis.
Multiple sclerosis or multiple possibilities: The continuing problem of misdiagnosis.
Sexual disparities in the incidence and course of MS.
Self-reported use of the upper limbs related to clinical tests in persons with multiple sclerosis.
The role of staphylococcal enterotoxin A in achieving oral tolerance to myelin basic protein in adult mice.
Central Nervous System Demyelination in a Charcot-Marie-Tooth Type 1A Patient.
Core outcome measures for exercise studies in people with multiple sclerosis: recommendations from a multidisciplinary consensus meeting.
Evaluation of brainstem involvement in multiple sclerosis.
ApoE-Deficient Promotes Blood-Brain Barrier Disruption in Experimental Autoimmune Encephalomyelitis via Alteration of MMP-9.
New data identify an increasing sex ratio of multiple sclerosis in Sweden.
Features of neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies.
The formation of inflammatory demyelinated lesions in cerebral white matter.
Will Biomarkers Determine What Is Next in Multiple Sclerosis?: Biomarkers in Multiple Sclerosis.
Trigeminal neuralgia: New classification and diagnostic grading for practice and research.
Fingolimod in the treatment of relapsing-remitting multiple sclerosis: long-term experience and an update on the clinical evidence.
Cannabidiol: promise and pitfalls.
Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europe.
Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities.
Bone mineral density and body composition in men with multiple sclerosis chronically treated with low-dose glucocorticoids.
Myasthenia gravis complicated with optic neuritis showing anti-aquaporin 4 antibody: a case report.
Characterization of the interaction between astrocytes and encephalitogenic lymphocytes during the development of experimental autoimmune encephalitomyelitis (EAE) in mice.

Pages